US Stock MarketDetailed Quotes

ACRS Aclaris Therapeutics

Watchlist
  • 1.220
  • +0.020+1.67%
Close Apr 29 16:00 ET
  • 1.180
  • -0.040-3.28%
Post 18:03 ET
86.94MMarket Cap-960P/E (TTM)

Aclaris Therapeutics Key Stats

Aclaris Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

17.57M

+126.62%
EPS(YoY)

-0.02

+95.12%

Hold

Apr 14, 2024

Aclaris Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 2.006M--
--2024/Q1-- / 2.000M--
--2023/Q417.570M / 5.051M--
--2023/Q39.282M / 1.574M--
--2023/Q21.869M / 1.899M--
May 8, 20232023/Q12.528M / 1.748M--
--2022/Q47.753M / 1.994M--
--2022/Q319.018M / 1.604M--
--2022/Q21.528M / 1.612M--
--2022/Q11.453M / 1.665M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 2.006M--
--2024/Q1-- / 2.000M--
--2023/Q417.570M / 5.051M--
--2023/Q39.282M / 1.574M--
--2023/Q21.869M / 1.899M--
May 8, 20232023/Q12.528M / 1.748M--
--2022/Q47.753M / 1.994M--
--2022/Q319.018M / 1.604M--
--2022/Q21.528M / 1.612M--
--2022/Q11.453M / 1.665M--

Unlock Free Earnings Estimates

Aclaris Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 14, 2024

Hold

  • Buy

    0.00%
  • Hold

    100.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg